Nea Management Company, LLC Black Diamond Therapeutics, Inc. Transaction History
Nea Management Company, LLC
- $1.06 Billion
- Q2 2024
A detailed history of Nea Management Company, LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 4,448,757 shares of BDTX stock, worth $18.8 Million. This represents 1.96% of its overall portfolio holdings.
Number of Shares
4,448,757
Previous 4,448,757
-0.0%
Holding current value
$18.8 Million
Previous $22.6 Million
8.09%
% of portfolio
1.96%
Previous 1.58%
Shares
3 transactions
Others Institutions Holding BDTX
# of Institutions
100Shares Held
47.3MCall Options Held
108KPut Options Held
24.8K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$45.1 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$36 Million0.66% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$13.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.13MShares$9.02 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.1MShares$8.88 Million0.73% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $154M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...